DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Cancer Discovery|2024Cited by 14
Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic TargetsVindhya Vijay, Nabeel Bardeesy, Lei Shi et al.|Cancer Discovery|2025Cited by 11
Data from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Unknown|2025Cited by 3
MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor–Resistant Cholangiocarcinoma and Attenuate the IFN ResponseJinkai Wan, N. Bardeesy|Clinical Cancer Research|2025Cited by 1
Correction: DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Cancer Discovery|2025Cited by 0